研究单位：[1]Pfizer[2]First Affiliated Hospital of Kunming Medical University Kunming,Yunnan,China,650032[3]Madera Family Medical Group Madera,California,United States,93637[4]Allergy & Asthma Associates of Southern California dba Southern California Research Mission Viejo,California,United States,92691[5]Sacramento,California,United States,95816[6]Moonshine Research Center,Inc. Doral,Florida,United States,33166[7]Homestead Research Institute Homestead,Florida,United States,33030[8]Olympian Clinical Research Largo,Florida,United States,33770[9]Clinical Trials Solutions Miami,Florida,United States,33126[10]La Salud Research Clinic,Inc. Miami,Florida,United States,33155
研究目的：
This is a randomized, double blind, placebo controlled, parallel group, Phase 3 study to evaluate the efficacy and safety of PF 04965842 in adolescent participants 12 to <18 years of age with moderate to severe AD.
